Indi(R) Announces Availability of Xpresys(TM) Lung Blood Test With Potential to Help Physicians Identify More Lung Nodules as Likely Benign and More Patients as Possible Candidates for Active Surveillance Instead of Invasive Procedures
28 oct. 2013 06h00 HE | Integrated Diagnostics
SEATTLE, WA--(Marketwired - Oct 28, 2013) - Indi (Integrated Diagnostics), an emerging leader in molecular diagnostics, today announced the availability of Xpresys Lung, a protein expression blood...